Aimei Health Technology Co., Ltd. (AFJK) is a pioneering force in the healthcare technology arena, dedicated to revolutionizing health solutions through its advanced digital platforms and innovative medical devices. The company excels in the rapidly expanding telehealth and personalized medicine sectors by leveraging cutting-edge artificial intelligence and data analytics to enhance patient outcomes and streamline healthcare delivery processes. Aimei's unwavering commitment to innovation not only drives operational efficiency across healthcare systems but also strategically positions the company for substantial growth, playing a crucial role in the evolving landscape of modern healthcare solutions.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.22% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | 15.77 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.17M |
| Float | $4.40M |
| % Insiders | 64.97% |
| % Institutions | 36.45% |
Volatility is currently contracting